Essex Woodlands Healthcare Partners
North America, California, United States, Palo Alto
Description
Essex Woodlands is a healthcare growth equity and venture capital firm.
Investor Profile
Essex Woodlands Healthcare Partners has made 129 investments, with 1 in the past 12 months and 49% as lead.
Stage Focus
- Series Unknown (28%)
- Series C (16%)
- Series D (13%)
- Post Ipo Equity (12%)
- Series B (8%)
- Series E (6%)
- Private Equity (6%)
- Series A (5%)
- Debt Financing (4%)
- Series F (2%)
Country Focus
- United States (83%)
- Canada (4%)
- United Kingdom (4%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Denmark (4%)
- China (2%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- France (1%)
- Switzerland (1%)
- Hong Kong (1%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
- Uruguay (1%)
'%3e%3cg id='c'%3e%3cg id='b'%3e%3cg id='a'%3e%3cpath stroke-linecap='square' d='m-2.058 8.889 3.01 4.494c-12.367 8.949-4.817 14.24-13.58 17.105 5.45-5.32-.859-5.767 3.733-16.854'/%3e%3cpath fill='none' d='M-4.21 10.163c-6.822 11.245-2.348 17.428-8.419 20.325'/%3e%3cpath d='M0 0h6L0 33-6 0h6v33'/%3e%3c/g%3e%3cuse xlink:href='%23a' transform='rotate(45)'/%3e%3c/g%3e%3cuse xlink:href='%23b' transform='rotate(90)'/%3e%3c/g%3e%3cuse xlink:href='%23c' transform='rotate(180)'/%3e%3ccircle r='11'/%3e%3c/g%3e%3cg transform='scale(.011)'%3e%3cg id='d'%3e%3cpath d='M81-44c-7 8-11-6-36-6S16-35 12-38s21-21 29-22 31 7 40 16m-29 9c7 6 1 19-6 19S26-28 32-36'/%3e%3cpath d='M19-26c1-12 11-14 27-14s23 12 29 15c-7 0-13-10-29-10s-16 0-27 10m3 2c4-6 9 6 20 6s17-3 24-8-10 12-21 12-26-6-23-10'/%3e%3cpath d='M56-17c13-7 5-17 0-19 2 2 10 12 0 19M0 43c6 0 8-2 16-2s27 11 38 7c-23 9-14 3-54 3h-5m63 6c-4-7-3-5-11-16 8 6 10 9 11 16M0 67c25 0 21-5 54-19-24 3-29 11-54 11h-5m5-29c7 0 9-5 17-5s19 3 24 7c1 1-3-8-11-9S25 9 16 7c0 4 3 3 4 9 0 5-9 5-11 0 2 8-4 8-9 8'/%3e%3c/g%3e%3cuse xlink:href='%23d' transform='scale(-1 1)'/%3e%3cpath d='M0 76c-5 0-18 3 0 3s5-3 0-3'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Medical Device
- Pharmaceutical
- Manufacturing
- Therapeutics
- Life Science
- Health Diagnostics
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
